Showing results (121-130 of 1,750) with videos related to
Sort By:
Pageof 175
The Keio Journal of Medicine|June 1, 1991
Clinical heterogeneity in acute myelogenous leukemia with the 8;21 translocationM Hagihara, H Kobayashi, H Miyachi, et al.Rinsho Byori. the Japanese Journal of Clinical Pathology|June 14, 2001
[Validity of reticulocyte count testing in reimbursement practice: a cost-effectiveness analysis]H Miyachi, Y Takemura, S Asai, et al.Cancer Letters|January 6, 1995
Expression of variant dihydrofolate reductase with decreased binding affinity to antifolates in MOLT-3 human leukemia cell lines resistant to trimetrexateH Miyachi, Y Takemura, H Kobayashi, et al.Rinsho Byori. the Japanese Journal of Clinical Pathology|December 11, 1999
[Inhibitory effects of therapeutic reagents on the PCR detection of hepatitis C virus in serum and their elimination by RNA extraction methods]A Masukawa, H Miyachi, T Ohshima, et al.Rinsho Byori. the Japanese Journal of Clinical Pathology|February 1, 1993
[Detection of drug resistant-genes in cisplatin-resistant colon carcinoma cells by RT-PCR assay. II]T Funato, T Tone, H Miyachi, et al.Investigational New Drugs|November 1, 1991
Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatinH Kobayashi, Y Takemura, H Miyachi, et al.Rinsho Byori. the Japanese Journal of Clinical Pathology|January 1, 1993
[Detection of drug resistant-gene in cisplatin-resistant colon carcinoma cells by RT-PCR assay. I]T Funato, T Tone, H Miyachi, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1991
A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717)Y Takemura, T Ohnuma, H Miyachi, et al.Japanese Journal of Cancer Research : Gann|November 25, 1997
Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folateH Miyachi, Y Takemura, H Kobayashi, et al.Bioorganic & Medicinal Chemistry|July 31, 1999
Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides: discovery of potent and subtype-selective antimuscarinic agentsH Miyachi, H Kiyota, H Uchiki, et al.Pageof 175